Mesa Science Associates to join CounterACT Researchers in Boston

April 12, 2017

Mesa Science Associates (MSA) announced today, April 12, 2017  plans to join Counter Act researchers and scientists at the 11th Annual NIH CounterACT Network Research Symposium. The Symposium will be held from  Monday, June 12 through Wednesday, June 14, 2017 at the Revere Hotel in Boston Mass. The company will be represented by MSA President, Mr. Michael Mesa. This will be Mr. Mesa’s 8th year at this unique conference and his 6th year representing MSA. He will join  colleagues and customers from around the country at this important scientific conference. MSA provides technical support to certain CounterACT researchers who are developing drugs and treatments aimed at defending the Homeland against chemical and biological threats. The company recently received an extension of a contract with the University of California San Diego to provide assistance to a Counter Act researcher in the planning of activities required to bring  a new drug entity to the IND stage of drug development.

UCdavid CounterACT

MSA News

Dr. Kenneth Dretchen PhD has been appointed as a member of the Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Discovery Research Award Committee.

May 22, 2020 This committee review grant applications for Pre-doctoral, Post-doctoral and Research Starter Grants dealing with innovative approaches that…

Read More

Mesa Science Associates and Bryn Pharma Publish Second Pre-Clinical Study of a New Approach to Treating Anaphylaxis

The second in a series of three studies measured the pharmacokinetic and heart rate effects of intranasal epinephrine in dogs….

Read More

Mesa Science Associates and Bryn Pharma Publish Pre-Clinical Study of a New Approach to Treating Anaphylaxis

April 13, 2020 Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the first of three…

Read More